Automated pH control using 1M sodium bicarbonate (not NaOH, which would cause localized pH spikes). Additionally, the team adds 50 mM arginine to the harvest hold tank, which acts as a chaotropic agent to stabilize the antibody.

In the biopharmaceutical industry, the term "A Mab" (Monoclonal Antibody) has become synonymous with the modern era of targeted therapeutics. With over 100 Mabs approved by the FDA and a global market exceeding $200 billion, these large, complex proteins have revolutionized the treatment of cancers, autoimmune diseases, and infectious diseases. However, the journey from a hybridoma cell line to a commercially viable drug product is a gauntlet of scientific and engineering challenges. A Mab A Case Study In Bioprocess Development

The development of a monoclonal antibody (mAb) bioprocess is a complex and challenging task. Monoclonal antibodies are a class of therapeutic proteins used to treat a wide range of diseases, including cancer, autoimmune disorders, and infectious diseases. The bioprocess development of a mAb involves several critical steps, including cell line development, fermentation, purification, and formulation. In this case study, we will explore the bioprocess development of a model mAb, "A Mab," from cell line development to commercial-scale production. Automated pH control using 1M sodium bicarbonate (not

This "flow-through" polishing step ensured that mAb-X achieved a purity level of . With over 100 Mabs approved by the FDA